macular neovascularization
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age > 18 years old; 2. Primary complaint of decreased vision, distorted vision, and the presence of black shadows before the eyes; 3. Eyes displaying features of FVHL in OCTA images of MNV patients; 4. OCTA image signal strength of >=6/10, with no significant motion or segmentation artifacts; 5. A follow-up period of no less than 3 months.
Exclusion criteria
Exclusion criteria: 1. History of other ocular diseases such as glaucoma, optic neuropathy, or diabetic retinopathy; 2. Presence of other serious systemic diseases including uncontrolled hypertension, diabetes, and systemic medications with known retinal toxicity; 3. Receipt of intravitreal anti-VEGF injections or other retinal surgeries within the past 6 months; 4. Incomplete medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of FVHL;OCTA characteristics of FVHL; | — |
Secondary
| Measure | Time frame |
|---|---|
| changes and outcomes of FVHL; | — |
Countries
China
Contacts
Xi'an Jiaotong University Second Affiliated Hospital